E-64 25mg 25mg | Purity Not Available
Adooq Bioscience
E-64 is an irreversible and selective cysteine protease inhibitor with IC50 of 9 nM for papain.
More Information Supplier PageSearch Results
E-64 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
E-64 is an irreversible and selective cysteine protease inhibitor with IC50 of 9 nM for papain.
More Information Supplier PageE-64 100mg 100mg | Purity Not Available
Adooq Bioscience
E-64 is an irreversible and selective cysteine protease inhibitor with IC50 of 9 nM for papain.
More Information Supplier PageCA-074 5mg 5mg | Purity Not Available
Adooq Bioscience
CA-074 25mg 25mg | Purity Not Available
Adooq Bioscience
CA-074 10mg 10mg | Purity Not Available
Adooq Bioscience
Loxistatin Acid 2mg 2mg | Purity Not Available
Adooq Bioscience
Loxistatin Acid, a derivative of E-64, is an irreversible and membrane-permeant cysteine protease inhibitor.
More Information Supplier PageLoxistatin Acid 5mg 5mg | Purity Not Available
Adooq Bioscience
Loxistatin Acid, a derivative of E-64, is an irreversible and membrane-permeant cysteine protease inhibitor.
More Information Supplier PagePRX-08066 5mg 5mg | Purity Not Available
Adooq Bioscience
PRX-08066, a Novel 5-Hydroxytryptamine Receptor 2B Antagonist, reduced monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
More Information Supplier PagePRX-08066 25mg 25mg | Purity Not Available
Adooq Bioscience
PRX-08066, a Novel 5-Hydroxytryptamine Receptor 2B Antagonist, reduced monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
More Information Supplier Page